サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1782001

抗菌薬耐性診断の世界市場：製品種類別・病原菌の種類別・技術別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Antimicrobial Resistance Diagnostics Market, By Product Type, By Pathogen Type, By Technology, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
抗菌薬耐性診断の世界市場：製品種類別・病原菌の種類別・技術別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

抗菌薬耐性診断の市場規模は2024年に46億1,022万米ドルとなり、2025年から2032年にかけてCAGR 6.90%で拡大

抗菌薬耐性診断の市場力学

タイムリーな治療決定を可能にする迅速・POC診断技術の採用が増加

迅速・POC（ポイントオブケア）診断技術は、医療従事者が耐性感染症を迅速に特定し、それに応じて治療を調整できるようにすることで、抗菌薬耐性との闘いに重要な役割を果たしています。何日もかかる従来の検査室での検査とは異なり、これらの高度な診断では数分から数時間で結果が得られるため、抗生物質の過剰使用や誤用を防ぐことができます。

2023年の世界保健機関（WHO）の報告によると、迅速診断法の使用により、不必要な抗生物質の処方が最大30～40％削減され、耐性菌の開発が大幅に抑制されることが示されています。さらに、より迅速で正確な検出は、タイムリーで的を絞った治療を促進し、入院期間を短縮し、ヘルスケア施設での感染拡大を抑制することで、患者の転帰を改善します。また、ポータブルPOCデバイスの利用可能性が高まることで、遠隔地や資源が限られた環境でも重要な診断機能を利用できるようになり、抗菌薬耐性を抑制するための世界の取り組みが強化されます。

例えば2025年3月、アボット・ラボラトリーズは、1時間以内に複数の抗菌薬耐性病原体を検出できる新しい迅速分子診断検査を発売しました。この検査は、耐性感染症の迅速な特定と分離を可能にすることで、病院の感染管理を強化し、患者管理と抗生物質スチュワードシップを向上させる。

抗菌薬耐性診断市場：主な考察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）に約6.90%のCAGRで毎年成長すると予測されています。

製品種類別では、試薬と消耗品が2024年に最大の市場シェアを示すと予測されています。

病原体の種類別では、メチシリン耐性黄色ブドウ球菌（MRSA）が2024年の主要病原体タイプでした。

技術別では、ポリメラーゼ連鎖反応（PCR）が2024年の主要技術でした。

最終用途別では、2024年には病院が主要なエンドユースでした。

地域別では、北米が2024年の売上高でトップ

抗菌薬耐性診断市場：セグメンテーション分析

世界の抗菌薬耐性診断市場は、製品タイプ、病原体タイプ、技術、エンドユース、地域に基づいてセグメント化されます。

製品タイプは、試薬・消耗品と機器の2つに分類されます。試薬・消耗品分野が市場を独占しています。これらのコンポーネントは、たまにしか購入しないような機器とは異なり、検査プロセスには欠かせないものです。試薬や消耗品は、診断検査のたびに必要とされるものであり、常に安定した需要があることを意味します。ヘルスケア施設やラボは、検査業務を円滑に進めるため、常に消耗品の補充に気を配っています。試薬や消耗品は、分子診断法、免疫測定法、培養法などのさまざまな診断プラットフォームに対応しています。この幅広い互換性により、様々な検査環境での使用が可能になります。その結果、病院、診断ラボ、ポイントオブケア施設は常にこれらの製品を必要としています。診断学における新しい技術は、しばしば特定の検査用に設計された新しい試薬を生み出し、市場をさらに拡大させる。試薬と消耗品の価格モデルは、機器の販売頻度の低さとは異なり、消耗品は安定した収益をもたらすため、メーカーにとって有益です。

市場は最終用途に基づき、病院、診断研究所、製薬・バイオテクノロジー企業、研究機関、その他の5つのカテゴリーに分けられます。病院部門が市場を独占しているが、この支配力は、感染症の診断と治療が頻繁に行われる主要な医療拠点が病院であることに起因しています。院内感染のリスクが高く、抗菌薬耐性を管理することが極めて重要であるため、病院は耐性病原体をタイムリーかつ正確に検出するための高度な診断ツールに多額の投資を行っています。さらに、病院は多くの場合、高度なAMR診断法を導入するためのインフラ、訓練を受けた人材、資金を有しており、大きな需要を牽引しています。感染制御プログラムや抗生物質管理における病院の役割は、この市場における主要なエンドユーザーとしての重要性をさらに際立たせています。

抗菌薬耐性診断市場：地域別分析

北米が世界の抗菌薬耐性診断薬市場を独占し、2024年の市場シェアは45.71%です。

北米は抗菌薬耐性診断薬の最大かつ最も成熟した市場であり、高度なヘルスケアインフラ、広範な研究開発活動、高い医療費に支えられています。主要診断企業の存在に加え、包括的な抗菌薬スチュワードシップ・プログラムや米国抗生物質耐性菌対策国家行動計画などの政府支援イニシアティブが、高度な診断ツールの採用を加速させています。この地域のヘルスケアと臨床検査室は、患者の転帰を改善し、医療関連感染を減らすために、耐性病原体を早期かつ正確に検出することを優先しています。さらに、強力な償還の枠組みや規制当局の支援が、革新的な診断薬への投資を促し、市場の成長をさらに促進しています。

アジア太平洋は、2024年の予測期間中、抗菌薬耐性診断薬市場で最も高いCAGRを記録すると予測されます。

一方、アジア太平洋は、人口の急増、都市化の進展、耐性株を持つ感染症の発生率の上昇などの要因が重なり、最も急速に成長している市場です。中国、インド、日本、韓国などの国々では、医療インフラの大幅な改善が進んでおり、感染症管理や診断能力への注目が高まっています。同地域の各国政府は、AMRを監視・管理するための啓発キャンペーンや政策を積極的に打ち出しており、迅速かつコスト効率の高い診断ソリューションの需要を押し上げています。さらに、中間所得層の増加とヘルスケア施設へのアクセス向上により、タイムリーな診断と治療を求める患者層が拡大しています。多剤耐性感染症の蔓延率の上昇、医療費の増加、国内外の診断企業間の提携などが相まって、アジア太平洋は、今後10年間に力強い成長が見込まれる、将来性の高い市場として位置づけられています。

抗菌薬耐性診断市場：競合情勢

抗菌薬耐性（AMR）診断市場は、市場ポジションを強化するために技術革新、戦略的提携、製品上市に注力する世界的・地域的企業の存在を特徴とする競合情勢にあります。主要企業は研究開発に多額の投資を行い、耐性病原体をタイムリーに検出する需要の高まりに対応した、迅速かつ正確で費用対効果の高い診断ソリューションを導入しています。

同市場の主要企業には、Roche Diagnostics、Abbott Laboratories、bioMerieux、Danaher Corporation（Cepheid）、QIAGEN、Thermo Fisher Scientificなどがあります。これらの企業は、幅広い製品ポートフォリオと強力な販売網を活用し、競合優位性を維持しています。また、医療機関や政府とパートナーシップを結び、市場への参入を拡大し、AMR監視プログラムを支援しています。

同市場では、より迅速で正確な結果を提供するマルチプレックス分子アッセイやPOC検査プラットフォームの開発など、技術的な進歩が頻繁に見られます。さらに、合併や買収は、能力を強化し新規市場に参入するために採用される一般的な戦略です。全体として、競合は継続的な技術革新を促し、抗菌薬耐性との闘いにおける診断精度の向上と患者の転帰を確実なものにしています。

目次

第1章 抗菌薬耐性診断市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 抗菌薬耐性診断の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 抗菌薬耐性診断市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制耐性の分析

第5章 抗菌薬耐性診断市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 抗菌薬耐性診断の市場情勢

  • 抗菌薬耐性診断の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 抗菌薬耐性診断市場：製品種類別

  • 概要
    • セグメント別シェア分析：製品種類別
    • 試薬・消耗品
    • 機器

第8章 抗菌薬耐性診断市場：病原体の種類別

  • 概要
    • セグメント別シェア分析：病原体の種類別
    • クロストリジウム・ディフィシル（CD）
    • 薬剤耐性カンピロバクター（DRC）
    • 薬剤耐性淋菌（DRNG）
    • 薬剤耐性肺炎球菌（DRSP）
    • メチシリン耐性黄色ブドウ球菌（MRSA）
    • その他の病原体の種類

第9章 抗菌薬耐性診断市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • 免疫測定
    • 質量分析
    • 微生物培養
    • 次世代シーケンシング（NGS）
    • ポリメラーゼ連鎖反応（PCR）
    • 迅速でポイントオブケア
    • その他の技術

第10章 抗菌薬耐性診断市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 診断検査室
    • 病院
    • 製薬・バイオテクノロジー企業
    • 研究機関
    • その他

第11章 抗菌薬耐性診断市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：抗菌薬耐性診断業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Abbott Laboratories
    • Accelerated Diagnostics, USA
    • Alifax
    • BD
    • Beckman Coulter
    • Becton, Dickinson and Company
    • BioMerieux
    • Bio-Rad Laboratories
    • Danaher
    • F. Hoffmann-La Roche
    • GeneFluidics
    • Hologic, Inc.
    • Molsid
    • OpGen
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Vela Diagnostics
    • Visby Medical, Inc.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV5383

REPORT HIGHLIGHT

Antimicrobial Resistance Diagnostics Market size was valued at US$ 4,610.22 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Antimicrobial Resistance (AMR) Diagnostics Market is the global industry that focuses on developing, producing, and selling diagnostic tools and technologies to detect antimicrobial-resistant pathogens. These diagnostics help identify resistance patterns in bacteria, viruses, fungi, and parasites. This information allows healthcare providers to prescribe effective treatments and prevent inappropriate use of antimicrobials. The market includes molecular diagnostics, immunoassays, microbiology techniques, and rapid point of care tests used in clinical, hospital, and research settings. As antimicrobial resistance rises worldwide and becomes a serious public health threat, the demand for timely and accurate AMR diagnostics is increasing significantly. This growth is driving innovation and investment in the field.

Antimicrobial Resistance Diagnostics Market- Market Dynamics

Increased adoption of rapid and point-of-care diagnostic technologies to enable timely treatment decisions

Rapid and point-of-care (POC) diagnostic technologies play a crucial role in combating antimicrobial resistance by enabling healthcare professionals to quickly identify resistant infections and tailor treatments accordingly. Unlike conventional laboratory tests that may take days, these advanced diagnostics provide results within minutes or hours, which helps prevent the overuse and misuse of antibiotics.

According to a 2023 World Health Organization (WHO) report, the use of rapid diagnostics has been shown to reduce unnecessary antibiotic prescriptions by up to 30-40%, significantly limiting the development of resistance. Additionally, faster and more accurate detection improves patient outcomes by facilitating timely, targeted therapies, reducing hospital stays, and curbing the spread of infections in healthcare facilities. The increasing availability of portable POC devices also ensures that even remote and resource-limited settings can access critical diagnostic capabilities, bolstering global efforts to contain antimicrobial resistance.

For Instance,

In March 2025, Abbott Laboratories launched a new rapid molecular diagnostic test capable of detecting multiple antimicrobial-resistant pathogens within an hour. This test enhances hospital infection control by enabling quick identification and isolation of resistant infections, improving patient management and antibiotic stewardship.

Antimicrobial Resistance Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on product type segmentation, reagents & consumables was predicted to show maximum market share in the year 2024

Based on pathogen type segmentation, methicillin-resistant staphylococcus aureus (MRSA) was the leading pathogen type in 2024

Based on technology segmentation, polymerase chain reaction (PCR) was the leading technology in 2024

Based on end use segmentation, hospitals was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Antimicrobial Resistance Diagnostics Market- Segmentation Analysis:

The global antimicrobial resistance diagnostics market is segmented on the basis of product type, pathogen type, technology, end use and region.

The market is divided into two categories based on product type: reagents & consumables and instruments. The reagents & consumables sector dominates the market. These components are essential for the testing process, unlike instruments that you might only buy once in a while. Reagents and consumables are needed for every single diagnostic test, which means there's a constant and reliable demand. Healthcare facilities and labs are always on the lookout to restock their supplies to keep their testing operations running smoothly. Reagents and consumables work well with different diagnostic platforms, including molecular diagnostics, immunoassays, and culture-based methods. This broad compatibility increases their use in various testing environments. As a result, hospitals, diagnostic labs, and point-of-care facilities consistently need these products. New technology in diagnostics often results in the creation of new reagents designed for specific tests, which grows the market even more. The pricing models for reagents and consumables benefit manufacturers since consumables provide steady revenue, unlike the less frequent sales of instruments.

The market is divided into five categories based on end-use: hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes and others. The hospitals sector dominates the market and this dominance stems from hospitals being the primary points of care where infections are frequently diagnosed and treated. Due to the high risk of hospital-acquired infections and the critical need to manage antimicrobial resistance, hospitals invest heavily in advanced diagnostic tools to ensure timely and accurate detection of resistant pathogens. Moreover, hospitals often have the infrastructure, trained personnel, and funding to implement sophisticated AMR diagnostics, driving substantial demand. Their role in infection control programs and antibiotic stewardship further underscores their importance as a key end user in this market.

Antimicrobial Resistance Diagnostics Market- Geographical Insights

North America dominates the global antimicrobial resistance diagnostics market, holding a 45.71% market share in 2024.

North America remains the largest and most mature market for antimicrobial resistance diagnostics, supported by advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending. The presence of leading diagnostic companies, coupled with comprehensive antimicrobial stewardship programs and government-backed initiatives such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria, has accelerated the adoption of sophisticated diagnostic tools. Hospitals and clinical laboratories in this region prioritize early and accurate detection of resistant pathogens to improve patient outcomes and reduce healthcare-associated infections. Additionally, strong reimbursement frameworks and regulatory support further drive market growth by encouraging investment in innovative diagnostics.

Asia Pacific is estimated to register the highest CAGR in the antimicrobial resistance diagnostics market during the forecast period in 2024.

The Asia-Pacific region, meanwhile, is the fastest-growing market due to a confluence of factors including a rapidly expanding population, increasing urbanization, and rising incidence of infectious diseases with resistant strains. Countries such as China, India, Japan, and South Korea are experiencing significant improvements in healthcare infrastructure, with increased focus on infectious disease management and diagnostic capacity. Governments in the region are actively launching awareness campaigns and implementing policies to monitor and control AMR, which boost demand for rapid and cost effective diagnostic solutions. Moreover, the growing middle class population and improved access to healthcare facilities create a larger patient base seeking timely diagnosis and treatment. The combination of rising prevalence of multidrug-resistant infections, greater healthcare funding, and partnerships between local and international diagnostic firms positions Asia-Pacific as a high-potential market with robust growth prospects over the coming decade.

Antimicrobial Resistance Diagnostics Market- Competitive Landscape:

The antimicrobial resistance (AMR) diagnostics market features a competitive landscape characterized by the presence of several global and regional players focusing on innovation, strategic collaborations, and product launches to strengthen their market position. Leading companies invest heavily in research and development to introduce rapid, accurate, and cost-effective diagnostic solutions that cater to the growing demand for timely detection of resistant pathogens.

Key players in the market include Roche Diagnostics, Abbott Laboratories, bioMerieux, Danaher Corporation (Cepheid), QIAGEN, and Thermo Fisher Scientific. These companies leverage their extensive product portfolios and strong distribution networks to maintain a competitive edge. They also engage in partnerships with healthcare institutions and governments to expand their market reach and support AMR surveillance programs.

The market is marked by frequent technological advancements such as the development of multiplex molecular assays and point of care testing platforms, which provide faster and more precise results. Additionally, mergers and acquisitions are common strategies employed to enhance capabilities and enter new markets. Overall, competition drives continuous innovation, ensuring better diagnostic accuracy and patient outcomes in the fight against antimicrobial resistance.

Recent Developments:

In March 2025, bioMerieux received FDA 510(k) clearance for its VITEK COMPACT PRO, a next-generation system combining microorganism identification and antibiotic susceptibility testing. This launch enhances clinical labs' capabilities to rapidly detect resistant pathogens, thereby supporting targeted treatments and improving patient management in the fight against AMR

In July 2024, QIAGEN announced a collaboration with a global healthcare provider to deploy its QIAstat-Dx Analyzer in regional clinics for rapid AMR diagnostics. This partnership aims to improve access to quick and accurate resistance testing outside traditional hospital settings, supporting early intervention

In September 2024, Thermo Fisher Scientific launched a new PCR-based diagnostic kit designed to rapidly detect antimicrobial-resistant pathogens in hospital settings. This innovation strengthens Thermo Fisher's position in the AMR diagnostics space by offering fast, accurate testing critical for effective antibiotic stewardship

In July 2022, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, along with the life sciences company Evotec SE and bioMerieux, announced a joint venture to develop the next generation of antimicrobials and actionable diagnostics to combat AMR. This collaboration helped the company broaden its product offerings for AMR diagnosis

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Accelerated Diagnostics, USA
  • Alifax
  • BD
  • Beckman Coulter
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • GeneFluidics
  • Hologic, Inc.
  • Molsid
  • OpGen
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Vela Diagnostics
  • Visby Medical, Inc.
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Consumables
  • Instruments

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032

  • Clostridium difficile (CD)
  • Drug-resistant campylobacter (DRC)
  • Drug-resistant Neisseria gonorrhoeae (DRNG)
  • Drug-resistant streptococcus pneumoniae (DRSP)
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Other pathogen types

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Immunoassay
  • Mass spectrometry
  • Microbiology culture
  • Next generation sequencing (NGS)
  • Polymerase chain reaction (PCR)
  • Rapid & point of care
  • Other technologies

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antimicrobial Resistance Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antimicrobial Resistance Diagnostics Market Snippet by Product Type
    • 2.1.2. Antimicrobial Resistance Diagnostics Market Snippet by Pathogen Type
    • 2.1.3. Antimicrobial Resistance Diagnostics Market Snippet by Technology
    • 2.1.4. Antimicrobial Resistance Diagnostics Market Snippet by End Use
    • 2.1.5. Antimicrobial Resistance Diagnostics Market Snippet by Country
    • 2.1.6. Antimicrobial Resistance Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Antimicrobial Resistance Diagnostics Key Market Trends

  • 3.1. Antimicrobial Resistance Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antimicrobial Resistance Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antimicrobial Resistance Diagnostics Market Opportunities
  • 3.4. Antimicrobial Resistance Diagnostics Market Future Trends

4. Antimicrobial Resistance Diagnostics Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antimicrobial Resistance Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Antimicrobial Resistance Diagnostics Market Landscape

  • 6.1. Antimicrobial Resistance Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antimicrobial Resistance Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Instruments

8. Antimicrobial Resistance Diagnostics Market - By Pathogen Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
    • 8.1.2. Clostridium difficile (CD)
    • 8.1.3. Drug-resistant campylobacter (DRC)
    • 8.1.4. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 8.1.5. Drug-resistant streptococcus pneumoniae (DRSP)
    • 8.1.6. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 8.1.7. Other pathogen types

9. Antimicrobial Resistance Diagnostics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Immunoassay
    • 9.1.3. Mass spectrometry
    • 9.1.4. Microbiology culture
    • 9.1.5. Next generation sequencing (NGS)
    • 9.1.6. Polymerase chain reaction (PCR)
    • 9.1.7. Rapid & point of care
    • 9.1.8. Other technologies

10. Antimicrobial Resistance Diagnostics Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Diagnostic Laboratories
    • 10.1.3. Hospitals
    • 10.1.4. Pharmaceutical & Biotechnology Companies
    • 10.1.5. Research Institutes
    • 10.1.6. Others

11. Antimicrobial Resistance Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antimicrobial Resistance Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Antimicrobial Resistance Diagnostics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Accelerated Diagnostics, USA
    • 12.2.3. Alifax
    • 12.2.4. BD
    • 12.2.5. Beckman Coulter
    • 12.2.6. Becton, Dickinson and Company
    • 12.2.7. BioMerieux
    • 12.2.8. Bio-Rad Laboratories
    • 12.2.9. Danaher
    • 12.2.10. F. Hoffmann-La Roche
    • 12.2.11. GeneFluidics
    • 12.2.12. Hologic, Inc.
    • 12.2.13. Molsid
    • 12.2.14. OpGen
    • 12.2.15. Roche Diagnostics
    • 12.2.16. Thermo Fisher Scientific
    • 12.2.17. Vela Diagnostics
    • 12.2.18. Visby Medical, Inc.
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us